InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
其他已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Explore the full record of transactions filed by Aklog Lishan. Director active across 2 companies, notably Lucid Diagnostics Inc.. In total, 7 reports have been published. Activity tracked since 7 January 2022. The latest transaction was disclosed on 2 April 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Aklog Lishan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报7 总计
350,000 股0Common StockSEC:0001094891-26-000165:0
2,170,000 股0Common StockSEC:0001094891-26-000083:0
150,000 股0Common StockSEC:0001094891-25-000039:0
300,000 股0Common StockSEC:0001062993-25-003218:0
400,000 股0Common stockSEC:0001062993-24-009637:0
79,636 股@ US$1.18100.0% 占其流量Common stockSEC:0001062993-22-010063:0
60,000 股0Common stockSEC:0001062993-22-000907:0
7 条申报中的 7 条
About Aklog Lishan
Aklog Lishan is a declarant associated with PAVmed Inc. and Lucid Diagnostics Inc., where he serves as Chairman and CEO and Chief Executive Officer. The record shows 7 filings in total, and across the recent sample of 7 filings, the modal transaction nature is Attribution, with a date range from 2022-01-10 to 2026-04-03.
